Literature DB >> 8232877

Correlation of MRI and clinical features in meningeal carcinomatosis.

M Watanabe1, R Tanaka, N Takeda.   

Abstract

Ten patients with meningeal carcinomatosis associated with nonhaematological neoplasms were examined: six with breast, two with gastrointestinal and one with lung cancer, plus one with a tumour of unknown origin. Cytology was positive in all but one. The patients were classified into four groups according to the gadolinium-enhanced MRI (Gd-MRI) appearances: group 1 had pure leptomeningeal carcinomatosis, group 2 dural carcinomatosis, group 3 spinal leptomeningeal carcinomatosis, and group 4 had normal Gd-MRI except for hydrocephalus. In group 1, Gd-MRI showed diffuse enhancement of the subarachnoid space, including the cisterns around the midbrain, the sylvian fissures, or cerebellar and cerebral sulci. In group 2, Gd-MRI showed diffuse, thick, partially nodular enhancement of the dura mater. No leptomeningeal or subependymal enhancement was evident. In group 3, nodular masses were seen only in the spinal canal. In group 4, no definite evidence of meningeal carcinomatosis was demonstrated on contrast-enhanced CT (CE-CT) or Gd-MRI. The median survival time was 2.0 months in group 1, 1.0 month in group 3, and 4.5 months in group 4, but the two patients in group 2 were alive 10 and 15 months after a definite diagnosis of meningeal carcinomatosis was made. In all patients examined by both CE-CT and Gd-MRI, the latter was superior for identification of meningeal carcinomatosis. Hydrocephalus in an important indirect sign of leptomeningeal carcinomatosis, but was not seen in patients with dural carcinomatosis despite the presence of increased intracranial pressure.

Entities:  

Mesh:

Year:  1993        PMID: 8232877     DOI: 10.1007/bf00588709

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  15 in total

1.  CNS metastases in small cell bronchogenic carcinoma: increasing frequency and changing pattern with lengthening survival.

Authors:  J L Nugent; P A Bunn; M J Matthews; D C Ihde; M H Cohen; A Gazdar; J D Minna
Journal:  Cancer       Date:  1979-11       Impact factor: 6.860

2.  Focal cerebral infarctions associated with perivascular tumor infiltrates in carcinomatous leptomeningeal metastases.

Authors:  P Klein; E C Haley; G F Wooten; S R VandenBerg
Journal:  Arch Neurol       Date:  1989-10

3.  Dural carcinomatosis: MR demonstration.

Authors:  R L Tyrrell; C V Bundschuh; M T Modic
Journal:  J Comput Assist Tomogr       Date:  1987 Mar-Apr       Impact factor: 1.826

4.  Infiltration of the leptomeninges by systemic cancer. A clinical and pathologic study.

Authors:  M E Olson; N L Chernik; J B Posner
Journal:  Arch Neurol       Date:  1974-02

5.  Meningeal carcinomatosis. Clinical manifestations.

Authors:  J R Little; A J Dale; H Okazaki
Journal:  Arch Neurol       Date:  1974-02

6.  Computed tomographic findings in metastatic dural carcinomatosis.

Authors:  D D Weaver; D L Cross; H R Winn; J A Jane
Journal:  Surg Neurol       Date:  1984-02

7.  Neuroradiologic findings in leptomeningeal carcinomatosis: the value interest of gadolinium-enhanced MRI.

Authors:  G Rodesch; P Van Bogaert; N Mavroudakis; P M Parizel; J J Martin; C Segebarth; M Van Vyve; D Baleriaux; J Hildebrand
Journal:  Neuroradiology       Date:  1990       Impact factor: 2.804

8.  Leptomeningeal metastasis: MR imaging.

Authors:  P C Davis; N C Friedman; S M Fry; J A Malko; J C Hoffmann; I F Braun
Journal:  Radiology       Date:  1987-05       Impact factor: 11.105

9.  Meningeal carcinomatosis in breast cancer.

Authors:  H Y Yap; B S Yap; C K Tashima; A DiStefano; G R Blumenschein
Journal:  Cancer       Date:  1978-07       Impact factor: 6.860

10.  Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients.

Authors:  W R Wasserstrom; J P Glass; J B Posner
Journal:  Cancer       Date:  1982-02-15       Impact factor: 6.860

View more
  5 in total

1.  Vascular endothelial growth factor antisense oligonucleotides inhibit leptomeningeal metastasis in vivo.

Authors:  Kangan Li; Guixiang Zhang; Jinglong Zhao; Xifu Wang; Yujie Li; Yunsheng Hu
Journal:  Med Oncol       Date:  2010-05-26       Impact factor: 3.064

2.  Outcome after whole brain radiotherapy alone in intracranial leptomeningeal carcinomatosis from solid tumors.

Authors:  C Gani; A C Müller; F Eckert; C Schroeder; B Bender; G Pantazis; M Bamberg; B Berger
Journal:  Strahlenther Onkol       Date:  2012-01-11       Impact factor: 3.621

3.  Diagnostic accuracy of MRI compared to CCT in patients with brain metastases.

Authors:  P D Schellinger; H M Meinck; A Thron
Journal:  J Neurooncol       Date:  1999       Impact factor: 4.130

4.  Leptomeningeal carcinomatosis from oesophageal cancer, presenting as meningitis.

Authors:  Mashrafi Ahmed; Tahmina Begum; Abdel Rahman Omer; Ishtiaque Amin Khan
Journal:  BMJ Case Rep       Date:  2016-01-06

5.  Blurring of the vessels of the interhemispheric fissure in multislice CT angiography: a sign of meningeal carcinomatosis.

Authors:  Birgit B Ertl-Wagner; Ralf-Thorsten Hoffmann; Roland Bruening; Karin Herrmann; Martin Dichgans; Maximilian F Reiser
Journal:  Eur Radiol       Date:  2004-02-19       Impact factor: 5.315

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.